MassMutual Private Wealth & Trust’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20
Closed 1912
2022
Q3
$0 Buy
+20
New +$232 ﹤0.01% 1877

MassMutual Private Wealth & Trust's AERI Position: Q4 2022 in Review

MassMutual Private Wealth & Trust sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 20 shares.

MassMutual Private Wealth & Trust first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • MassMutual Private Wealth & Trust reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 20 Aerie Pharmaceuticals shares in Q4 2022.
  • MassMutual Private Wealth & Trust first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Aerie Pharmaceuticals position peaked at $0 in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2022, filed 6 Jan 2023.